<DOC>
	<DOC>NCT01895855</DOC>
	<brief_summary>the purpose of the study is to determine if PXVX0200 is safe and effective in preventing cholera infection</brief_summary>
	<brief_title>Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera</brief_title>
	<detailed_description />
	<mesh_term>Cholera</mesh_term>
	<criteria>healthy men or women, age 18 to 45 years inclusive; normal medical history and physical examination; and no clinically significant abnormalities from: urine dipstick for glucose, protein, and blood, complete blood count, serum hepatic transaminases, total bilirubin (direct if abnormal), creatinine, electrolytes, albumin, or electrocardiogram. Women must have a negative pregnancy test. travel to a cholera endemic area in the previous 5 years; abnormal stool pattern or regular use of laxatives; history of eating disorders (such as bulimia), anal or rectal disorders, allergy to tetracycline and/or ciprofloxacin; history of cholera or enterotoxigenic E. coli challenge; current or recent antibiotic use; pregnancy or nursing; positive serology for HIV, hepatitis B antigen, or hepatitis C; any immunosuppressive medical condition; history of hospitalization for psychiatric illness or use of specific psychiatric drugs.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>